首页> 外国专利> Method for screening osteoclast differentiation inhibitor and agent for preventing or treating bone metabolism disorder

Method for screening osteoclast differentiation inhibitor and agent for preventing or treating bone metabolism disorder

机译:筛选破骨细胞分化抑制剂的方法及预防或治疗骨代谢异常的药物

摘要

The present invention provides an osteoclast differentiation inhibitor that can be used as a therapeutic agent for diseases of abnormal bone metabolism. Moreover, the screening method which searches the said osteoclast differentiation formation inhibitor is provided. The osteoclast differentiation inhibitor of the present invention comprises a substance that inhibits the binding of c-Src and ADAP (adhesion of degranulation-promoting adaptor protein) in monocyte-derived macrophage-like cells as an active ingredient. The screening method for osteoclast differentiation inhibitor of the present invention includes (a) a step of contacting c-Src and ADAP in the presence of a test substance, and (b) binding of c-Src and ADAP. And (c) selecting a test substance that inhibits the binding of c-Src and ADAP as an osteoclast differentiation inhibitor.
机译:本发明提供了破骨细胞分化抑制剂,其可用作骨代谢异常的疾病的治疗剂。另外,提供一种搜索上述破骨细胞分化形成抑制剂的筛选方法。本发明的破骨细胞分化抑制剂包含抑制单核细胞来源的巨噬细胞样细胞中c-Src和ADAP(脱粒促进衔接蛋白的粘附)的结合的物质作为有效成分。本发明的破骨细胞分化抑制剂的筛选方法包括(a)在测试物质存在下使c-Src和ADAP接触的步骤,以及(b)c-Src和ADAP的结合。并且(c)选择抑制c-Src和ADAP结合的测试物质作为破骨细胞分化抑制剂。

著录项

  • 公开/公告号JPWO2006135069A1

    专利类型

  • 公开/公告日2009-01-08

    原文格式PDF

  • 申请/专利号JP20070521369

  • 发明设计人 竹家 達夫;

    申请日2006-06-16

  • 分类号A61K38;C12N9/99;C12N5/06;C12Q1/48;A61P43;A61P19/10;A61P29;A61P19/02;A61P19/08;A61P35;A61P1/02;G01N33/50;G01N33/15;C12N15/09;

  • 国家 JP

  • 入库时间 2022-08-21 19:37:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号